ストックスクリーナーアプリを入手
4.20
4.74%
0.19
アフターアワーズ：
4.20
前日終値:
$4.01
開ける：
$4
24時間の取引高:
2.83M
Relative Volume:
3.38
時価総額：
$805.13M
収益：
$12.99M
当期純損益:
$-74.39M
株価収益率:
-9.5455
EPS:
-0.44
ネットキャッシュフロー:
$-78.92M
1週間 パフォーマンス:
+13.21%
1か月 パフォーマンス:
+23.17%
6か月 パフォーマンス:
+21.39%
1年 パフォーマンス:
-6.87%
1日の値動き範囲:
$4.00
$4.37
1週間の範囲:
$3.66
$4.37
52週間の値動き範囲:
$2.705
$4.725
Arbutus Biopharma Corp Stock (ABUS) Company Profile
名前
Arbutus Biopharma Corp
セクター
電話
604-419-3200
住所
701 VETERANS CIRCLE, WARMINSTER, PA
ABUS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.20 | 768.71M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-02-02 | アップグレード | Jefferies | Hold → Buy |
| 2021-02-25 | 開始されました | Jefferies | Hold |
| 2020-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2020-07-27 | 再開されました | JMP Securities | Mkt Outperform |
| 2020-07-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-03-06 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | 開始されました | Robert W. Baird | Outperform |
| 2020-02-05 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | 繰り返されました | B. Riley FBR | Buy |
| 2019-10-04 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | アップグレード | Wedbush | Underperform → Neutral |
| 2018-10-12 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-07-06 | ダウングレード | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | 再開されました | Chardan Capital Markets | Buy |
| 2018-03-19 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-01-05 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | 繰り返されました | Wedbush | Outperform |
| 2016-12-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | アップグレード | Chardan Capital Markets | Neutral → Buy |
すべてを表示
Arbutus Biopharma Corp (ABUS) 最新ニュース
Arbutus Biopharma Corporation stock daily chart insights2025 Big Picture & Free High Return Stock Watch Alerts - Newser
Chart based analysis of Arbutus Biopharma Corporation trendsQuarterly Market Summary & Expert Approved Momentum Ideas - Newser
How is Arbutus Biopharma Corporation managing supply chain issuesQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - خودرو بانک
Volume spikes in Arbutus Biopharma Corporation stock – what they meanJuly 2025 Summary & High Yield Equity Trading Tips - Newser
Arbutus Biopharma Corporation stock outlook for YEARBond Market & Safe Entry Point Alerts - Newser
Using AI based signals to follow Arbutus Biopharma CorporationJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
What MACD and RSI say about Arbutus Biopharma CorporationEarnings Summary Report & Weekly Stock Performance Updates - Newser
Custom watchlist performance reports with Arbutus Biopharma CorporationQuarterly Market Summary & Real-Time Volume Analysis Alerts - Newser
How to read the order book for Arbutus Biopharma CorporationQuarterly Profit Report & AI Driven Price Forecasts - Newser
Can Arbutus Biopharma Corporation benefit from deglobalizationJuly 2025 Analyst Calls & Reliable Intraday Trade Plans - khodrobank.com
Using data models to predict Arbutus Biopharma Corporation stock movementLong Setup & Safe Capital Growth Stock Tips - Newser
Does Arbutus Biopharma Corporation qualify in momentum factor screening2025 Market Overview & Weekly High Return Opportunities - Newser
Multi asset correlation models including Arbutus Biopharma Corporation2025 Analyst Calls & Technical Pattern Alert System - Newser
Can swing trading help recover from Arbutus Biopharma Corporation losses2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Using flow based indicators on Arbutus Biopharma CorporationWeekly Market Summary & Reliable Intraday Trade Alerts - Newser
Real time scanner hits for Arbutus Biopharma Corporation explainedWeekly Earnings Recap & Low Risk High Reward Ideas - Newser
Technical signs of recovery in Arbutus Biopharma CorporationQuarterly Investment Review & Real-Time Volume Spike Alerts - Newser
Is Arbutus Biopharma Corporation stock entering bullish territoryMarket Volume Summary & Free AI Powered Buy and Sell Recommendations - Newser
Real time pattern detection on Arbutus Biopharma Corporation stockMarket Volume Report & Weekly High Momentum Picks - Newser
Will Arbutus Biopharma Corporation outperform the marketJuly 2025 Intraday Action & Fast Gain Stock Tips - Newser
Should value investors consider Arbutus Biopharma CorporationEarnings Risk Report & Expert Verified Stock Movement Alerts - خودرو بانک
Analyzing recovery setups for Arbutus Biopharma Corporation investorsRate Cut & Free Weekly Watchlist of Top Performers - Newser
Is Arbutus Biopharma Corporation vulnerable to short sellersMarket Movement Recap & Daily Profit Maximizing Tips - خودرو بانک
Published on: 2025-09-03 05:15:59 - Newser
Can a trend reversal in Arbutus Biopharma Corporation lead to recoverySwing Trade & Expert Curated Trade Setups - Newser
Tools to monitor Arbutus Biopharma Corporation recovery probability2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Can Arbutus Biopharma Corporation sustain earnings growth2025 Growth vs Value & Trade Opportunity Analysis - خودرو بانک
Arbutus Biopharma Corporation’s volatility index tracking explained2025 Performance Recap & Risk Managed Trade Strategies - Newser
Is Arbutus Biopharma Corporation trending in predictive chart modelsJuly 2025 Summary & Daily Stock Trend Reports - Newser
What are Arbutus Biopharma Corporation’s technical support levelsJuly 2025 Highlights & Long-Term Capital Growth Strategies - khodrobank.com
Nuveen LLC Invests $1.09 Million in Arbutus Biopharma Corporation $ABUS - Defense World
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Is Arbutus Biopharma Corporation undervalued by DCF analysisMarket Growth Report & Reliable Price Breakout Signals - khodrobank.com
How to build a custom watchlist for Arbutus Biopharma CorporationJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser
Analyst Upgrade: How is Arbutus Biopharma Corporation managing supply chain issuesWeekly Profit Recap & Free Community Supported Trade Ideas - khodrobank.com
Is Arbutus Biopharma Corporation likely to announce a buybackLayoff News & Smart Swing Trading Alerts - khodrobank.com
Is Arbutus Biopharma Corporation on track to beat earningsJuly 2025 Technicals & Fast Entry and Exit Trade Plans - خودرو بانک
Technical analysis overview for Arbutus Biopharma Corporation stock - Newser
Measuring Arbutus Biopharma Corporation’s beta against major indicesPrice Action & Weekly Market Pulse Alerts - Newser
Published on: 2025-08-30 22:10:35 - Newser
Applying sector rotation models to Arbutus Biopharma CorporationWeekly Trend Recap & Technical Confirmation Alerts - Newser
Developing predictive dashboards with Arbutus Biopharma Corporation dataMarket Sentiment Summary & Accurate Buy Signal Alerts - Newser
Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MSN
Arbutus Biopharma Corp (ABUS) 財務データ
収益
当期純利益
現金流量
EPS
1.40%
大文字化:
|
ボリューム (24 時間):